US 8,618,134 B2 · Method and composition for treating a serotonin receptor-mediated condition

Abstract

A method and composition for treating serotonin receptor-mediated conditions.

Dependent claims

A method for antagonizing a 5-HT2A receptor in an animal suffering from a condition that is mediated by a 5-HT2A receptor, the method comprising:

internally administering to the animal an effective amount of 4-[3-[4-(6-fluoro-1,2,-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-benzoic acid or pharmaceutically-acceptable salt thereof in a controlled release pharmaceutical dosage form.

Dependencies are inferred from the claim text.

Facts

Application

12/747,912Filed 13 Dec 2008 · us provisional application

Priority

13 Dec 2007

Published

US 2011/0044971 A124 Feb 2011

Granted

31 Dec 2013

Term ends

Not estimatedThe source records don’t support an estimate.

A61K 31/454
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A61K 31/445
Non condensed pyridines; Hydrogenated derivatives thereof: non condensed piperidines, e.g. piperocaine
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics

A method and composition for treating serotonin receptor-mediated conditions.

Dependent claims

A method for antagonizing a 5-HT2A receptor in an animal suffering from a condition that is mediated by a 5-HT2A receptor, the method comprising:

internally administering to the animal an effective amount of 4-[3-[4-(6-fluoro-1,2,-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-benzoic acid or pharmaceutically-acceptable salt thereof in a controlled release pharmaceutical dosage form.

Dependencies are inferred from the claim text.